JP2020511410A5 - - Google Patents

Download PDF

Info

Publication number
JP2020511410A5
JP2020511410A5 JP2019531241A JP2019531241A JP2020511410A5 JP 2020511410 A5 JP2020511410 A5 JP 2020511410A5 JP 2019531241 A JP2019531241 A JP 2019531241A JP 2019531241 A JP2019531241 A JP 2019531241A JP 2020511410 A5 JP2020511410 A5 JP 2020511410A5
Authority
JP
Japan
Prior art keywords
ethyl
tetrahydropyran
azepine
pyrazolo
spiro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019531241A
Other languages
English (en)
Japanese (ja)
Other versions
JP7008073B2 (ja
JP2020511410A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/082424 external-priority patent/WO2018108910A1/en
Publication of JP2020511410A publication Critical patent/JP2020511410A/ja
Publication of JP2020511410A5 publication Critical patent/JP2020511410A5/ja
Application granted granted Critical
Publication of JP7008073B2 publication Critical patent/JP7008073B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019531241A 2016-12-12 2017-12-12 置換ピラゾロアゼピン-4-オンおよびそれらのホスホジエステラーゼ阻害剤としての使用 Expired - Fee Related JP7008073B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16203335.1 2016-12-12
EP16203335 2016-12-12
PCT/EP2017/082424 WO2018108910A1 (en) 2016-12-12 2017-12-12 Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors

Publications (3)

Publication Number Publication Date
JP2020511410A JP2020511410A (ja) 2020-04-16
JP2020511410A5 true JP2020511410A5 (cg-RX-API-DMAC7.html) 2021-01-21
JP7008073B2 JP7008073B2 (ja) 2022-01-25

Family

ID=57542834

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019531241A Expired - Fee Related JP7008073B2 (ja) 2016-12-12 2017-12-12 置換ピラゾロアゼピン-4-オンおよびそれらのホスホジエステラーゼ阻害剤としての使用

Country Status (7)

Country Link
US (2) US11065257B2 (cg-RX-API-DMAC7.html)
EP (1) EP3551632B1 (cg-RX-API-DMAC7.html)
JP (1) JP7008073B2 (cg-RX-API-DMAC7.html)
CN (1) CN110167944B (cg-RX-API-DMAC7.html)
ES (1) ES2981006T3 (cg-RX-API-DMAC7.html)
RU (1) RU2768746C2 (cg-RX-API-DMAC7.html)
WO (1) WO2018108910A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018286964B2 (en) 2017-06-20 2022-04-14 UNION therapeutics A/S Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
WO2019115776A1 (en) 2017-12-15 2019-06-20 Leo Pharma A/S Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors
GB202306662D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Dosage regimen

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2803299B1 (fr) * 2000-01-05 2004-09-17 Warner Lambert Co NOUVELLES PYRAZOLO [4,3-e] DIAZEPINES SUBSTITUEES, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT, UTILISATION A TITRE DE MEDICAMENT ET PROCEDES POUR LEUR PREPARATION
US7423031B2 (en) 2003-05-01 2008-09-09 Irm Llc Compounds and compositions as protein kinase inhibitors
AR058071A1 (es) * 2005-10-03 2008-01-23 Astrazeneca Ab Derivados de dihidropirazolo (3,4-e)(1,4)diazepina. procesos de obtencion y composiciones farmaceuticas.
WO2007115232A2 (en) * 2006-03-30 2007-10-11 Chemocentryx, Inc. Cxcr4 modulators
CA2669886A1 (en) * 2006-11-15 2008-05-22 Vertex Pharmaceuticals Incorporated Compounds useful as protein kinase inhibitors
PL2114951T3 (pl) * 2007-02-28 2014-10-31 Leo Pharma As Nowe inhibitory fosfodiesterazy
GB0704652D0 (en) 2007-03-09 2007-04-18 Syngenta Participations Ag Novel herbicides
WO2011003005A1 (en) * 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine mch-1 antagonists, methods of making, and use thereof
CN110088108B (zh) * 2016-12-12 2024-06-14 联合疗法公司 取代的吡唑并氮杂䓬-4-酮类及其作为磷酸二酯酶抑制剂的用途
ES2874632T3 (es) * 2016-12-12 2021-11-05 Union Therapeutics As Pirazoloazepin-8-onas sustituidas y su uso como inhibidores de la fosfodiesterasa

Similar Documents

Publication Publication Date Title
US12528818B2 (en) Compositions and methods for inhibition of RAS
JP7611278B2 (ja) 金属酵素阻害剤化合物
CN1902196B (zh) 噻唑衍生物
AU2008322595B2 (en) Method of treating arthritis
EP2736904B1 (en) Oxazole and thiazole derivatives as selective protein kinase inhibitors (c-kit)
JP2022554392A5 (cg-RX-API-DMAC7.html)
CA2918284A1 (en) Autotaxin inhibitors comprising a heteroaromatic ring-benzyl-amide-cycle core
CN116531380A (zh) 用于治疗癌症的2-杂芳基-3-氧代-2,3-二氢哒嗪-4-甲酰胺
RU2015154987A (ru) Гетероциклические производные
WO2011041461A2 (en) Polycyclic compounds as lysophosphatidic acid receptor antagonists
JP6706023B2 (ja) 線維症の小分子阻害剤
JP7216719B2 (ja) 置換ジヒドロチエノピリミジンおよびホスホジエステラーゼ阻害剤としてのその使用
JP2016503785A5 (cg-RX-API-DMAC7.html)
JP2020536915A5 (cg-RX-API-DMAC7.html)
CN112236416A (zh) 嘧啶环己烯基糖皮质激素受体调节剂
JP2021501183A5 (cg-RX-API-DMAC7.html)
JP2019532974A5 (cg-RX-API-DMAC7.html)
RU2019121694A (ru) Замещенные пиразолоазепин-4-оны и их применение в качестве ингибиторов фосфодиэстеразы
CN110088108A (zh) 取代的吡唑并氮杂*-4-酮类及其作为磷酸二酯酶抑制剂的用途
CN106188027A (zh) 芳杂环类衍生物及其在药物中的应用
JP2024545552A (ja) Ripk1阻害剤として縮合したヘテロ環
KR101764458B1 (ko) 치환 피리딘 화합물
KR20100021444A (ko) 플루오로퀴놀론을 사용하여 염증을 조절하기 위한 조성물 및 방법
JP2008137892A (ja) 止痒剤
KR101323083B1 (ko) 퀴나졸린 유도체 및 의약